◼ Archived
Business
Thyroid medicine recall receives FDA's highest risk level
A thyroid medication recall issued by Vitruvias Therapeutics has been upgraded by the FDA to the highest risk classification.
1 trends tracked about this subject — the full history, oldest to newest below.
A thyroid medication recall issued by Vitruvias Therapeutics has been upgraded by the FDA to the highest risk classification.